Cefazolin Leads to Better Outcomes for Methicillin-susceptible Staphylococcus aureus Bacteremia Than Nafcillin or Oxacillin.

Cefazolin Leads to Better Outcomes for Methicillin-susceptible Staphylococcus aureus Bacteremia Than Nafcillin or Oxacillin.

Watkins Richard R

Infectious Disease Alert

2017

2017-08

A retrospective study that included patients from 119 Veterans Affairs hospitals found lower mortality and a similar recurrence rate for methicillin-susceptible Staphylococcus aureus bacteremia treated with cefazolin compared to nafcillin and oxacillin.

Treatment Outcomes; Staphylococcal Infections – Drug Therapy; Treatment Outcomes – Evaluation; Bacteremia – Drug Therapy; Cefazolin – Therapeutic Use; Drug Therapy – Evaluation; Nafcillin – Therapeutic Use; Oxacillin – Therapeutic Use; Vancomycin – Therapeutic Use

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

3–4

11

36